Bacil Pharma Balance Sheet Annual

BSE: 524516 | NSE: - | ISIN: INE711D01018 | Sector: Biotechnology & Drugs

45.17 +0.87 (1.96%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.04	0.03	0.23	0.10
Short Term Investments	0.00	0.19	0.26	0.14
Cashand Short Term Investments	0.04	0.22	0.49	0.24
Accounts Receivable- Trade Net	0.00	0.00	0.00	0.00
Total Receivables Net	0.00	0.00	0.00	0.00
Other Current Assets Total	0.01	0.01	0.01	0.06
Total Current Assets	0.05	0.23	0.50	0.30
Property/ Plant/ Equipment Total- Net	0.01	0.01	0.01	0.01
Long Term Investments	0.61	0.24	0.05	0.24
Note Receivable- Long Term	0.60	0.54	0.60	0.93
Other Long Term Assets Total	0.06	0.12	0.11	2.61
Total Assets	1.33	1.13	1.27	4.09
Accounts Payable	0.00	0.00	0.01	0.01
Notes Payable/ Short Term Debt	0.10	0.02	0.03	0.18
Other Currentliabilities Total	0.01	0.01	0.00	2.51
Total Current Liabilities	0.11	0.03	0.05	2.70
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	0.10	0.02	0.03	0.18
Deferred Income Tax	0.00	0.00	0.00	0.00
Other Liabilities Total	0.00	0.00	0.00	0.00
Total Liabilities	0.11	0.03	0.05	2.70
Common Stock Total	6.53	6.53	6.53	6.53
Other Equity Total	-5.31	-5.43	-5.30	-5.14
Total Equity	1.21	1.10	1.22	1.39
Total Liabilities Shareholders' Equity	1.33	1.13	1.27	4.09
Total Common Shares Outstanding	0.59	0.59	0.59	0.59
Tangible Book Valueper Share Common Eq	2.06	1.87	2.08	2.36